Costa del Sol’s Malaga hospital participates in new drug trial to fight Covid-19

The study will analyse the efficiency and security of an anitiviral drug called Remdesivir to treat Covid-19 patients. Photo: Shutterstock

Costa del Sol’s Hospital Clinico de Malaga has announced that it is participating in a drug trial for coronavirus (Covid-19), with the University Hospital of Virgen de Sevilla.

THE study will analyse an anitiviral drug called Remdesivir to treat Covid-19 patients. According to the hospital, the trial will analyse the efficiency and safety of the drug on patients who have moderate and serious Covid-19 infections.

The trial forms part of a much larger international study, and involves at least 13 Spanish hospitals, including the Malaga’s Virgen de la Victoria University Hospital.

FacebookTwitterRedditWhatsAppTelegramLinkedInEmailCopy Link
Go Back
Written by

Pepi Sappal

Share your story with us by emailing [email protected], by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews

Comments


    Leave a comment

    Your email address will not be published.